Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Leidos appoints Thomas Sanglier as chief audit executive » 16:16
07/05/22
07/05
16:16
07/05/22
16:16
LDOS

Leidos

$99.60 /

-2.89 (-2.82%)

, RTX

Raytheon Technologies

$92.92 /

-3.96 (-4.09%)

Leidos (LDOS) announced…

Leidos (LDOS) announced the appointment of Thomas Sanglier as the company's new chief audit executive. In this role, Sanglier will oversee the company's internal audit function and deliver assessments and assurance. Sanglier brings more than 32 years of experience in the areas of financial and operational auditing, risk assessment, and internal control. He most recently served as Senior Director, Finance & Operations Internal Audit at Raytheon Technologies (RTX).

ShowHide Related Items >><<
RTX Raytheon Technologies
$92.92 /

-3.96 (-4.09%)

LDOS Leidos
$99.60 /

-2.89 (-2.82%)

LDOS Leidos
$99.60 /

-2.89 (-2.82%)

06/07/22 Barclays
Leidos downgraded to Equal Weight from Overweight at Barclays
05/04/22 Truist
Leidos price target raised to $120 from $108 at Truist
04/13/22 Goldman Sachs
CACI downgraded to Neutral from Buy at Goldman Sachs
03/24/22 Wells Fargo
Wells Fargo downgrades Leidos to Equal Weight, raises price target to $113
RTX Raytheon Technologies
$92.92 /

-3.96 (-4.09%)

04/27/22 Argus
Raytheon Technologies price target raised to $112 from $100 at Argus
04/27/22 Cowen
Raytheon Technologies price target raised to $120 from $115 at Cowen
04/08/22 RBC Capital
Raytheon Technologies initiated with an Outperform at RBC Capital
03/29/22 Jefferies
Northrop among biggest beneficiaries of DoD budget request, says Jefferies
RTX Raytheon Technologies
$92.92 /

-3.96 (-4.09%)

LDOS Leidos
$99.60 /

-2.89 (-2.82%)

RTX Raytheon Technologies
$92.92 /

-3.96 (-4.09%)

LDOS Leidos
$99.60 /

-2.89 (-2.82%)

RTX Raytheon Technologies
$92.92 /

-3.96 (-4.09%)

LDOS Leidos
$99.60 /

-2.89 (-2.82%)

RTX Raytheon Technologies
$92.92 /

-3.96 (-4.09%)

Thursday
Hot Stocks
Booz Allen 'strongly disagrees' with DOJ on proposed EverWatch transaction » 13:23
06/30/22
06/30
13:23
06/30/22
13:23
BAH

Booz Allen

$90.40 /

+1.84 (+2.08%)

Booz Allen Hamilton has…

Booz Allen Hamilton has issued the following statement regarding its proposed EverWatch acquisition, from company spokesperson Jessica Klenk: "For 108 years Booz Allen Hamilton has served clients with integrity and dedication. We are proud of the work we do in service of our government partners to help address some of the toughest problems this country faces. We take very seriously our responsibility to provide the most innovative and effective solutions to meet critical national missions. We strongly disagree with the Department of Justice's characterization of the proposed $440 million, approximately 500-person EverWatch transaction. We believe the acquisition would bring together two companies with complementary capabilities to support our collective national security interests and would enhance competition overall in an industry that is highly competitive. The transaction would accelerate technology development cycles and enable faster delivery of classified software development and analytics for national security clients, including AI, full-spectrum cyber operations, mission analytics, 5G, and TechSIGINT capabilities. Grounded in Booz Allen's culture, values, and commitment to national security missions, this transaction would drive major digital and cyber transformation in the Intelligence Community and beyond, creating a more comprehensive portfolio of offerings to a wider range of intelligence and defense clients. Booz Allen believes the transaction would deliver significant benefits to our government clients and we refute any suggestion that the proposed transaction would harm government agencies or taxpayers."

ShowHide Related Items >><<
BAH Booz Allen
$90.40 /

+1.84 (+2.08%)

BAH Booz Allen
$90.40 /

+1.84 (+2.08%)

06/14/22 Cowen
Booz Allen price target lowered to $103 from $109 at Cowen
06/07/22 Barclays
Booz Allen downgraded to Equal Weight from Overweight at Barclays
05/25/22 Raymond James
Booz Allen price target raised to $96 from $90 at Raymond James
05/18/22 William Blair
William Blair cautious on Booz Allen shares into Friday's earnings
BAH Booz Allen
$90.40 /

+1.84 (+2.08%)

BAH Booz Allen
$90.40 /

+1.84 (+2.08%)

Wednesday
Hot Stocks
DOJ sues to block Booz Allen's proposed acquisition of EverWatch » 18:18
06/29/22
06/29
18:18
06/29/22
18:18
BAH

Booz Allen

$88.48 /

+0.985 (+1.13%)

The U.S. Department of…

The U.S. Department of Justice filed a civil antitrust lawsuit to block Booz Allen Hamilton Holding Corporation's proposed acquisition of EverWatch Corp., a subsidiary of EC Defense Holdings LLC. The complaint, filed in the U.S. District Court for the District of Maryland, alleges that the merger agreement threatens imminent competition for a government contract to provide operational modeling and simulation services to the National Security Agency. Unless enjoined, the transaction would eliminate competition for this defense contract, leaving NSA to face a monopoly bidder. "Booz Allen's agreement to acquire EverWatch imperils competition in a market that is vital to our national security," said Assistant Attorney General Jonathan Kanter of the Justice Department's Antitrust Division. "Both the acquisition agreement and the underlying transaction violate federal antitrust law."

ShowHide Related Items >><<
BAH Booz Allen
$88.48 /

+0.985 (+1.13%)

BAH Booz Allen
$88.48 /

+0.985 (+1.13%)

06/14/22 Cowen
Booz Allen price target lowered to $103 from $109 at Cowen
06/07/22 Barclays
Booz Allen downgraded to Equal Weight from Overweight at Barclays
05/25/22 Raymond James
Booz Allen price target raised to $96 from $90 at Raymond James
05/18/22 William Blair
William Blair cautious on Booz Allen shares into Friday's earnings
BAH Booz Allen
$88.48 /

+0.985 (+1.13%)

BAH Booz Allen
$88.48 /

+0.985 (+1.13%)

Over a week ago
Hot Stocks
Leidos announces DES contract valued at up to $11.5B upheld by GAO » 16:32
06/22/22
06/22
16:32
06/22/22
16:32
LDOS

Leidos

$97.48 /

+0.57 (+0.59%)

Leidos announced that the…

Leidos announced that the Defense Enclave Services contract awarded by the Defense Information Systems Agency was upheld by the Government Accountability Office after a thorough and disciplined review. The single-award, indefinite delivery, indefinite quantity contract was initially awarded in February 2022 and holds a total estimated value of $11.5B if all options are exercised. It includes a four-year base period of performance followed by three two-year option periods.

ShowHide Related Items >><<
LDOS Leidos
$97.48 /

+0.57 (+0.59%)

LDOS Leidos
$97.48 /

+0.57 (+0.59%)

06/07/22 Barclays
Leidos downgraded to Equal Weight from Overweight at Barclays
05/04/22 Truist
Leidos price target raised to $120 from $108 at Truist
04/13/22 Goldman Sachs
CACI downgraded to Neutral from Buy at Goldman Sachs
03/24/22 Wells Fargo
Wells Fargo downgrades Leidos to Equal Weight, raises price target to $113
LDOS Leidos
$97.48 /

+0.57 (+0.59%)

LDOS Leidos
$97.48 /

+0.57 (+0.59%)

LDOS Leidos
$97.48 /

+0.57 (+0.59%)

Hot Stocks
KBR JV awarded contract by BP Exploration for SDA platform » 09:14
06/20/22
06/20
09:14
06/20/22
09:14
KBR

KBR

$44.35 /

+0.185 (+0.42%)

KBR announced that its…

KBR announced that its SOCAR-KBR joint venture has been awarded a front-end engineering design, turnaround engineering, and procurement support services contract by BP Exploration for the Shah Deniz Alpha platform in Azerbaijan. This project will significantly reduce SDA's overall carbon footprint and increase operational efficiency, providing a robust, long-term, high-availability power supply. SOCAR-KBR will be responsible for the FEED services for decommissioning the existing five main power generators on the SDA platform. They will then create a power supply from the KBR-designed Shah Deniz Bravo platform through subsea cables and a back-up power generator. This project will be delivered from SOCAR-KBR's Baku office to maximize local execution, with specialist subject matter expert support provided from KBR's London operations.

ShowHide Related Items >><<
KBR KBR
$44.35 /

+0.185 (+0.42%)

KBR KBR
$44.35 /

+0.185 (+0.42%)

04/14/22 KeyBanc
KBR price target raised to $66 from $55 at KeyBanc
03/17/22 Stifel
KBR resumed with a Buy at Stifel
03/11/22 Truist
KBR price target raised to $64 from $57 at Truist
03/04/22 DA Davidson
DA Davidson upgrades KBR to Buy as geopolitics boosts defense contractors
KBR KBR
$44.35 /

+0.185 (+0.42%)

Hot Stocks
Leidos selected by Punta Cana Airport to upgrade security checkpoints » 05:18
06/16/22
06/16
05:18
06/16/22
05:18
LDOS

Leidos

$98.76 /

+0.81 (+0.83%)

Leidos was selected by…

Leidos was selected by the Dominican Republic's Punta Cana International Airport, or PUJ, to upgrade their security checkpoints. The airport will utilize Leidos' technologies to keep passengers and staff safe while enhancing operational efficiencies and increasing passenger throughput.

ShowHide Related Items >><<
LDOS Leidos
$98.76 /

+0.81 (+0.83%)

LDOS Leidos
$98.76 /

+0.81 (+0.83%)

06/07/22 Barclays
Leidos downgraded to Equal Weight from Overweight at Barclays
05/04/22 Truist
Leidos price target raised to $120 from $108 at Truist
04/13/22 Goldman Sachs
CACI downgraded to Neutral from Buy at Goldman Sachs
03/24/22 Wells Fargo
Wells Fargo downgrades Leidos to Equal Weight, raises price target to $113
LDOS Leidos
$98.76 /

+0.81 (+0.83%)

LDOS Leidos
$98.76 /

+0.81 (+0.83%)

LDOS Leidos
$98.76 /

+0.81 (+0.83%)

Hot Stocks
KBR to acquire VIMA Group, terms undisclosed » 06:46
06/15/22
06/15
06:46
06/15/22
06:46
KBR

KBR

$47.34 /

-0.505 (-1.06%)

KBR announced it has…

KBR announced it has entered into a definitive agreement to acquire U.K.-based VIMA Group, a provider of digital transformation solutions to defense and other public sector clients, for up to GBP 75M, inclusive of earn-out opportunities. VIMA Group delivers solutions across a number of large-scale, high priority digital transformation programs to support its clients in ensuring availability of effective digital and information technology as guided by the U.K.'s Digital Strategy for Defence.

ShowHide Related Items >><<
KBR KBR
$47.34 /

-0.505 (-1.06%)

KBR KBR
$47.34 /

-0.505 (-1.06%)

04/14/22 KeyBanc
KBR price target raised to $66 from $55 at KeyBanc
03/17/22 Stifel
KBR resumed with a Buy at Stifel
03/11/22 Truist
KBR price target raised to $64 from $57 at Truist
03/04/22 DA Davidson
DA Davidson upgrades KBR to Buy as geopolitics boosts defense contractors
KBR KBR
$47.34 /

-0.505 (-1.06%)

Recommendations
Booz Allen price target lowered to $103 from $109 at Cowen » 07:35
06/14/22
06/14
07:35
06/14/22
07:35
BAH

Booz Allen

$82.77 /

-1.695 (-2.01%)

Cowen analyst Cai von…

Cowen analyst Cai von Rumohr lowered the firm's price target on Booz Allen to $103 from $109 and keeps an Outperform rating on the shares. The analyst called it a "pure play" defense IT leader and said it is positioned for the sector's fastest organic growth in 2023 after two years of lagging peers. He said key drivers are robust booking prospects and an improving net hiring environment as the economy slows.

ShowHide Related Items >><<
BAH Booz Allen
$82.77 /

-1.695 (-2.01%)

BAH Booz Allen
$82.77 /

-1.695 (-2.01%)

06/07/22 Barclays
Booz Allen downgraded to Equal Weight from Overweight at Barclays
05/25/22 Raymond James
Booz Allen price target raised to $96 from $90 at Raymond James
05/18/22 William Blair
William Blair cautious on Booz Allen shares into Friday's earnings
04/13/22 Goldman Sachs
CACI downgraded to Neutral from Buy at Goldman Sachs
BAH Booz Allen
$82.77 /

-1.695 (-2.01%)

BAH Booz Allen
$82.77 /

-1.695 (-2.01%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 09:39
06/07/22
06/07
09:39
06/07/22
09:39
PLXS

Plexus

$84.73 /

+0.79 (+0.94%)

, PFHC

ProFrac Holding

$20.22 /

+0.67 (+3.43%)

, RLI

RLI Corp.

$119.52 /

+0.3 (+0.25%)

, MRTX

Mirati Therapeutics

$43.23 /

-1.055 (-2.38%)

, LEA

Lear

$140.91 /

+2.44 (+1.76%)

, XOM

Exxon Mobil

$98.85 /

-0.245 (-0.25%)

, ALNY

Alnylam

$131.74 /

+0.47 (+0.36%)

, SNCE

Science 37

$4.16 /

+0.165 (+4.14%)

, GXO

GXO Logistics

$55.29 /

+0.79 (+1.45%)

, OXY

Occidental Petroleum

$69.54 /

-0.74 (-1.05%)

, BAH

Booz Allen

$87.99 /

+0.79 (+0.91%)

, EAF

GrafTech

$9.06 /

+0.14 (+1.57%)

, DVN

Devon Energy

$77.07 /

+0.055 (+0.07%)

, PRAX

Praxis Precision Medicines

$1.88 /

-6.665 (-78.04%)

, TXMD

TherapeuticsMD

$9.95 /

+0.04 (+0.40%)

, MCK

McKesson

$317.69 /

+1.24 (+0.39%)

Institutional investors…

ShowHide Related Items >><<
XOM Exxon Mobil
$98.85 /

-0.245 (-0.25%)

TXMD TherapeuticsMD
$9.95 /

+0.04 (+0.40%)

SNCE Science 37
$4.16 /

+0.165 (+4.14%)

RLI RLI Corp.
$119.52 /

+0.3 (+0.25%)

PRAX Praxis Precision Medicines
$1.88 /

-6.665 (-78.04%)

PLXS Plexus
$84.73 /

+0.79 (+0.94%)

OXY Occidental Petroleum
$69.54 /

-0.74 (-1.05%)

MRTX Mirati Therapeutics
$43.23 /

-1.055 (-2.38%)

MCK McKesson
$317.69 /

+1.24 (+0.39%)

LEA Lear
$140.91 /

+2.44 (+1.76%)

GXO GXO Logistics
$55.29 /

+0.79 (+1.45%)

EAF GrafTech
$9.06 /

+0.14 (+1.57%)

DVN Devon Energy
$77.07 /

+0.055 (+0.07%)

BAH Booz Allen
$87.99 /

+0.79 (+0.91%)

ALNY Alnylam
$131.74 /

+0.47 (+0.36%)

PLXS Plexus
$84.73 /

+0.79 (+0.94%)

06/07/22 Raymond James
Plexus upgraded to Outperform from Market Perform at Raymond James
01/28/22 Needham
Plexus price target lowered to $90 from $95 at Needham
08/23/21 Fox Advisors
Plexus upgraded to Overweight from Equal Weight at Fox Advisors
06/22/21 Sidoti
Plexus upgraded to Buy from Neutral at Sidoti
PFHC ProFrac Holding
$20.22 /

+0.67 (+3.43%)

06/07/22 Seaport Global
ProFrac Holding initiated with a Buy at Seaport Global
06/07/22 Piper Sandler
ProFrac Holding initiated with an Overweight at Piper Sandler
06/07/22 JPMorgan
ProFrac Holding initiated with an Overweight at JPMorgan
06/07/22 Stifel
ProFrac Holding initiated with a Buy at Stifel
RLI RLI Corp.
$119.52 /

+0.3 (+0.25%)

06/07/22 Raymond James
RLI Corp. initiated with a Market Perform at Raymond James
04/22/22 RBC Capital
RLI Corp. price target raised to $123 from $112 at RBC Capital
03/14/22 Keefe Bruyette
Keefe Bruyette sees special dividend following RLI stake sale
02/22/22 Compass Point
RLI Corp. upgraded to Buy at Compass Point after recent weakness
MRTX Mirati Therapeutics
$43.23 /

-1.055 (-2.38%)

06/07/22 Stifel
Mirati Therapeutics price target raised to $111 from $105 at Stifel
06/07/22 JMP Securities
Mirati Therapeutics upgraded to Outperform from Market Perform at JMP Securities
05/27/22 Stifel
Mirati Therapeutics after-hours move lower 'overdone,' says Stifel
05/20/22 Guggenheim
Guggenheim upgrades Mirati to Buy on adagrasib's 'highly competitive profile'
LEA Lear
$140.91 /

+2.44 (+1.76%)

06/07/22 Wells Fargo
Wells Fargo upgrades Lear on valuation, electric vehicle 'optionality'
06/07/22 Wells Fargo
Lear upgraded to Overweight from Equal Weight at Wells Fargo
06/01/22 Goldman Sachs
Lear price target lowered to $158 from $163 at Goldman Sachs
06/01/22 Morgan Stanley
Lear price target lowered to $144 from $160 at Morgan Stanley
XOM Exxon Mobil
$98.85 /

-0.245 (-0.25%)

06/07/22 Evercore ISI
Evercore upgrades Exxon Mobil, sees 'achievable' path to doubling earnings
06/07/22 Credit Suisse
Exxon Mobil price target raised to $115 from $102 at Credit Suisse
06/07/22 Evercore ISI
Exxon Mobil upgraded to Outperform from In Line at Evercore ISI
06/03/22 JPMorgan
Exxon Mobil share rally 'still has room,' says JPMorgan
ALNY Alnylam
$131.74 /

+0.47 (+0.36%)

06/07/22 William Blair
Alnylam initiated with an Outperform at William Blair
05/02/22 H.C. Wainwright
Alnylam price target raised to $430 from $400 at H.C. Wainwright
04/29/22 Citi
Alnylam price target lowered to $211 from $223 at Citi
04/25/22 Morgan Stanley
Alnylam downgraded to Equal Weight from Overweight at Morgan Stanley
SNCE Science 37
$4.16 /

+0.165 (+4.14%)

06/07/22 Craig-Hallum
Science 37 initiated with a Buy at Craig-Hallum
11/16/21 Lake Street
Science 37 price target raised to $20 from $15 at Lake Street
11/01/21 Lake Street
Lake Street starts Science 37 at Buy, says digitized trials 'here to stay'
11/01/21 Lake Street
Science 37 initiated with a Buy at Lake Street
GXO GXO Logistics
$55.29 /

+0.79 (+1.45%)

06/07/22 Barclays
GXO Logistics reinstated with an Equal Weight at Barclays
06/06/22 Cowen
GXO Logistics initiated with an Outperform at Cowen
05/09/22 Oppenheimer
GXO Logistics price target lowered to $91 from $108 at Oppenheimer
04/20/22 Citi
GXO Logistics price target lowered to $90 from $110 at Citi
OXY Occidental Petroleum
$69.54 /

-0.74 (-1.05%)

06/07/22 Evercore ISI
Evercore 'taking some chips off the table,' downgrades Devon Energy to In Line
06/07/22 Evercore ISI
Occidental Petroleum downgraded to In Line from Outperform at Evercore ISI
05/31/22 Mizuho
Occidental Petroleum price target raised to $89 from $85 at Mizuho
05/12/22 Wells Fargo
Occidental Petroleum price target raised to $58 from $51 at Wells Fargo
BAH Booz Allen
$87.99 /

+0.79 (+0.91%)

06/07/22 Barclays
Booz Allen downgraded to Equal Weight from Overweight at Barclays
05/25/22 Raymond James
Booz Allen price target raised to $96 from $90 at Raymond James
05/18/22 William Blair
William Blair cautious on Booz Allen shares into Friday's earnings
04/13/22 Goldman Sachs
CACI downgraded to Neutral from Buy at Goldman Sachs
EAF GrafTech
$9.06 /

+0.14 (+1.57%)

06/07/22 Citi
GrafTech downgraded to Neutral at Citi on lack of near-term catalysts
06/07/22 Citi
GrafTech downgraded to Neutral from Buy at Citi
05/17/22 GLJ Research
GrafTech price target lowered to $4.93 from $6.72 at GLJ Research
08/10/21 RBC Capital
GrafTech price target lowered to $14 from $16 at RBC Capital
DVN Devon Energy
$77.07 /

+0.055 (+0.07%)

06/07/22 Evercore ISI
Devon Energy downgraded to In Line from Outperform at Evercore ISI
05/31/22 Mizuho
Devon Energy price target raised to $92 from $89 at Mizuho
05/25/22 Barclays
Devon Energy downgraded to Equal Weight from Overweight at Barclays
PRAX Praxis Precision Medicines
$1.88 /

-6.665 (-78.04%)

06/07/22 BofA
Praxis Precision Medicines downgraded to Neutral from Buy at BofA
06/07/22 H.C. Wainwright
Praxis Precision price target lowered to $10 from $48 at H.C. Wainwright
06/06/22 Wedbush
Wedbush downgrades Praxis to Neutral, slashes target after ARIA trial failure
06/06/22 Wedbush
Praxis Precision Medicines downgraded to Neutral from Outperform at Wedbush
TXMD TherapeuticsMD
$9.95 /

+0.04 (+0.40%)

06/07/22 H.C. Wainwright
TherapeuticsMD downgraded to Neutral from Buy at H.C. Wainwright
05/06/22 Cantor Fitzgerald
TherapeuticsMD downgraded to Neutral from Overweight at Cantor Fitzgerald
05/06/22 Cantor Fitzgerald
TherapeuticsMD downgraded to Neutral from Overweight at Cantor Fitzgerald
03/11/22 H.C. Wainwright
TherapeuticsMD price target lowered to $2.50 from $3 at H.C. Wainwright
MCK McKesson
$317.69 /

+1.24 (+0.39%)

06/07/22 Deutsche Bank
Deutsche Bank upgrades McKesson to Buy amid recession concerns
06/07/22 Deutsche Bank
McKesson upgraded to Buy from Hold at Deutsche Bank
05/11/22 Credit Suisse
McKesson price target raised to $377 from $333 at Credit Suisse
05/10/22 Deutsche Bank
McKesson price target raised to $343 from $270 at Deutsche Bank
XOM Exxon Mobil
$98.85 /

-0.245 (-0.25%)

TXMD TherapeuticsMD
$9.95 /

+0.04 (+0.40%)

SNCE Science 37
$4.16 /

+0.165 (+4.14%)

RLI RLI Corp.
$119.52 /

+0.3 (+0.25%)

PRAX Praxis Precision Medicines
$1.88 /

-6.665 (-78.04%)

PLXS Plexus
$84.73 /

+0.79 (+0.94%)

OXY Occidental Petroleum
$69.54 /

-0.74 (-1.05%)

MRTX Mirati Therapeutics
$43.23 /

-1.055 (-2.38%)

MCK McKesson
$317.69 /

+1.24 (+0.39%)

LEA Lear
$140.91 /

+2.44 (+1.76%)

GXO GXO Logistics
$55.29 /

+0.79 (+1.45%)

EAF GrafTech
$9.06 /

+0.14 (+1.57%)

DVN Devon Energy
$77.07 /

+0.055 (+0.07%)

BAH Booz Allen
$87.99 /

+0.79 (+0.91%)

ALNY Alnylam
$131.74 /

+0.47 (+0.36%)

  • 13
    May
  • 11
    Nov
XOM Exxon Mobil
$98.85 /

-0.245 (-0.25%)

OXY Occidental Petroleum
$69.54 /

-0.74 (-1.05%)

MCK McKesson
$317.69 /

+1.24 (+0.39%)

XOM Exxon Mobil
$98.85 /

-0.245 (-0.25%)

TXMD TherapeuticsMD
$9.95 /

+0.04 (+0.40%)

SNCE Science 37
$4.16 /

+0.165 (+4.14%)

PRAX Praxis Precision Medicines
$1.88 /

-6.665 (-78.04%)

PLXS Plexus
$84.73 /

+0.79 (+0.94%)

PFHC ProFrac Holding
$20.22 /

+0.67 (+3.43%)

OXY Occidental Petroleum
$69.54 /

-0.74 (-1.05%)

MRTX Mirati Therapeutics
$43.23 /

-1.055 (-2.38%)

MCK McKesson
$317.69 /

+1.24 (+0.39%)

LEA Lear
$140.91 /

+2.44 (+1.76%)

EAF GrafTech
$9.06 /

+0.14 (+1.57%)

DVN Devon Energy
$77.07 /

+0.055 (+0.07%)

BAH Booz Allen
$87.99 /

+0.79 (+0.91%)

ALNY Alnylam
$131.74 /

+0.47 (+0.36%)

XOM Exxon Mobil
$98.85 /

-0.245 (-0.25%)

TXMD TherapeuticsMD
$9.95 /

+0.04 (+0.40%)

OXY Occidental Petroleum
$69.54 /

-0.74 (-1.05%)

MCK McKesson
$317.69 /

+1.24 (+0.39%)

DVN Devon Energy
$77.07 /

+0.055 (+0.07%)

Hot Stocks
Booz Allen awarded NASA CyPrESS contract » 08:12
06/07/22
06/07
08:12
06/07/22
08:12
BAH

Booz Allen

$87.99 /

+0.79 (+0.91%)

Booz Allen Hamilton…

Booz Allen Hamilton announced it was awarded the National Aeronautics and Space Administration, NASA, Cybersecurity and Privacy Enterprise Solutions and Services, CyPrESS, contract-a hybrid indefinite-delivery/indefinite-quantity, IDIQ, single award contract with a total potential value of $622.5M-to provide a complete range of cybersecurity and privacy enterprise solutions and services for NASA's Office of the Chief Information Officer, OCIO. For the first time, this contract brings together all aspects of cybersecurity across the NASA enterprise under one contract to include IT systems, operational technology systems, and mission systems. Work will support all NASA centers and facilities from May 31, 2022 through September 30, 2023, with four option periods running through September 2030. "We're honored that NASA has awarded Booz Allen with the groundbreaking CyPrESS IDIQ contract, which seeks-for the first time-to centralize NASA's cybersecurity posture under one strategic line of work," said Andrea Inserra, executive vice president at Booz Allen Hamilton. "We recognize that NASA's current cyber needs must advance and evolve to protect its more complex missions of the future, and we look forward to building on our long-standing partnership to support NASA's important research, missions, and operations-paving the way to send humans beyond the Moon to Mars-while protecting its people, assets, and information from threats."

ShowHide Related Items >><<
BAH Booz Allen
$87.99 /

+0.79 (+0.91%)

BAH Booz Allen
$87.99 /

+0.79 (+0.91%)

06/07/22 Barclays
Booz Allen downgraded to Equal Weight from Overweight at Barclays
05/25/22 Raymond James
Booz Allen price target raised to $96 from $90 at Raymond James
05/18/22 William Blair
William Blair cautious on Booz Allen shares into Friday's earnings
04/13/22 Goldman Sachs
CACI downgraded to Neutral from Buy at Goldman Sachs
BAH Booz Allen
$87.99 /

+0.79 (+0.91%)

BAH Booz Allen
$87.99 /

+0.79 (+0.91%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.